This section includes information and resources about Cancer for journalists: Boehringer Ingelheim press releases, background information, related press kits and a collection of images and videos.
Boehringer Ingelheim and Priaxon announce a collaboration to research and develop novel treatments for cancer
Boehringer Ingelheim initiates first Phase III clinical trial in Ovarian Cancer
Boehringer Ingelheim to commence Phase III study investigating the role of BIBW 2992 as first-line treatment for non-small cell lung cancer (NSCLC) patients with EGFR mutations
Boehringer Ingelheim to present new phase II clinical data on two lead oncology compounds at ASCO 2009
First pivotal trials begin for Boehringer Ingelheim’s novel triple angiokinase inhibitor Vargatef™ (BIBF 1120)